Key takeaways from SABCS 2024: PATINA and other highlights

17 Просмотры

  • Спасибо! Поделитесь с друзьями!

    Вам не понравилось видео. Спасибо за то что поделились своим мнением!

admin
Издатель
Claudine Isaacs, MD, Georgetown University, Washington, DC, provides an overview of highlights from the 2024 San Antonio Breast Cancer Symposium (SABCS), including omitting sentinel or axillary node dissection in patients receiving radiotherapy. The PATINA trial (NCT02947685) also demonstrated significant survival benefits with palbociclib in maintenance therapy, marking a potential shift in clinical practice. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Категория
Рак Молочной Железы
Комментариев нет.

Следующее